Literature DB >> 29269526

Hematopoietic stem cell transplantation for patients with paroxysmal nocturnal hemoglobinuria previously treated with eculizumab: a retrospective study of 21 patients from SFGM-TC centers.

Nicolas Vallet1, Flore Sicre de Fontbrune2, Michaël Loschi3, Deborah Desmier4, Alban Villate1, Fiorenza Barraco5, Patrice Chevallier6, Louis Terriou7, Ibrahim Yakoub-Agha7, Annalisa Ruggeri8, Mohamad Mohty8, Natacha Maillard4, Pierre-Simon Rohrlich9, Patrice Ceballos10, Stéphanie Nguyen11, Xavier Poiré12, Gaëlle Guillerm13, Reza Tabrizi14, Jonathan Farhi15, Raynier Devillier16, Marie-Thérèse Rubio17, Gérard Socié2, Régis Peffault de Latour18.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29269526      PMCID： PMC5830366          DOI： 10.3324/haematol.2017.182360

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  14 in total

1.  Competing risk analysis using R: an easy guide for clinicians.

Authors:  L Scrucca; A Santucci; F Aversa
Journal:  Bone Marrow Transplant       Date:  2007-06-11       Impact factor: 5.483

2.  The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria.

Authors:  Peter Hillmen; Neal S Young; Jörg Schubert; Robert A Brodsky; Gerard Socié; Petra Muus; Alexander Röth; Jeffrey Szer; Modupe O Elebute; Ryotaro Nakamura; Paul Browne; Antonio M Risitano; Anita Hill; Hubert Schrezenmeier; Chieh-Lin Fu; Jaroslaw Maciejewski; Scott A Rollins; Christopher F Mojcik; Russell P Rother; Lucio Luzzatto
Journal:  N Engl J Med       Date:  2006-09-21       Impact factor: 91.245

Review 3.  Paroxysmal nocturnal hemoglobinuria.

Authors:  Robert A Brodsky
Journal:  Blood       Date:  2014-09-18       Impact factor: 22.113

4.  Allogeneic stem cell transplantation in paroxysmal nocturnal hemoglobinuria.

Authors:  Régis Peffault de Latour; Hubert Schrezenmeier; Andrea Bacigalupo; Didier Blaise; Carmino A de Souza; Stephane Vigouroux; Roelf Willemze; Louis Terriou; Andre Tichelli; Mohamad Mohty; Sophie de Guibert; Judith C Marsh; Jakob Passweg; Jean Yves Mary; Gerard Socié
Journal:  Haematologica       Date:  2012-06-11       Impact factor: 9.941

5.  Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival.

Authors:  Richard J Kelly; Anita Hill; Louise M Arnold; Gemma L Brooksbank; Stephen J Richards; Matthew Cullen; Lindsay D Mitchell; Dena R Cohen; Walter M Gregory; Peter Hillmen
Journal:  Blood       Date:  2011-04-01       Impact factor: 22.113

6.  Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories.

Authors:  Régis Peffault de Latour; Jean Yves Mary; Célia Salanoubat; Louis Terriou; Gabriel Etienne; Mohamad Mohty; Sophie Roth; Sophie de Guibert; Sebastien Maury; Jean Yves Cahn; Gerard Socié
Journal:  Blood       Date:  2008-06-05       Impact factor: 22.113

7.  Eculizumab, a terminal complement inhibitor, improves anaemia in patients with paroxysmal nocturnal haemoglobinuria.

Authors:  Jörg Schubert; Peter Hillmen; Alexander Röth; Neal S Young; Modupe O Elebute; Jeffrey Szer; Giacomo Gianfaldoni; Gérard Socié; Paul Browne; Robert Geller; Russell P Rother; Petra Muus
Journal:  Br J Haematol       Date:  2008-05-22       Impact factor: 6.998

8.  Eculizumab before and after allogeneic hematopoietic stem cell transplantation in a patient with paroxysmal nocturnal hemoglobinuria.

Authors:  Hakan Göker; Burak Uz; Yahya Büyükaşık; Salih Aksu; İbrahim Haznedaroğlu; Nilgün Sayınalp; Yasemin Karacan; Fatma Tekin; Osman İlhami Özcebe
Journal:  Turk J Haematol       Date:  2011-09-05       Impact factor: 1.831

Review 9.  1994 Consensus Conference on Acute GVHD Grading.

Authors:  D Przepiorka; D Weisdorf; P Martin; H G Klingemann; P Beatty; J Hows; E D Thomas
Journal:  Bone Marrow Transplant       Date:  1995-06       Impact factor: 5.483

10.  Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria.

Authors:  Robert A Brodsky; Neal S Young; Elisabetta Antonioli; Antonio M Risitano; Hubert Schrezenmeier; Jörg Schubert; Anna Gaya; Luke Coyle; Carlos de Castro; Chieh-Lin Fu; Jaroslaw P Maciejewski; Monica Bessler; Henk-André Kroon; Russell P Rother; Peter Hillmen
Journal:  Blood       Date:  2007-11-30       Impact factor: 22.113
View more
  6 in total

1.  Concurrent treatment of aplastic anemia/paroxysmal nocturnal hemoglobinuria syndrome with immunosuppressive therapy and eculizumab: a UK experience.

Authors:  Morag Griffin; Austin Kulasekararaj; Sheyans Gandhi; Talha Munir; Stephen Richards; Louise Arnold; Nana Benson-Quarm; Nicola Copeland; Isabel Duggins; Kathryn Riley; Peter Hillmen; Judith Marsh; Anita Hill
Journal:  Haematologica       Date:  2018-03-15       Impact factor: 9.941

2.  Eculizumab Bridging before Bone Marrow Transplant for Marrow Failure Disorders Is Safe and Does Not Limit Engraftment.

Authors:  Amy E DeZern; Richard J Jones; Robert A Brodsky
Journal:  Biol Blood Marrow Transplant       Date:  2018-07-26       Impact factor: 5.742

3.  Haploidentical vs matched sibling donor transplant for paroxysmal nocturnal haemoglobinuria: A multicenter study.

Authors:  Limin Liu; Shunqing Wang; Erlie Jiang; Yanming Zhang; Jianyong Li; Yuewen Fu; Meiqing Lei; Kailin Xu; Mingzhen Yang; Yinghao Lu; Miao Miao; Depei Wu
Journal:  Blood Cancer J       Date:  2022-06-24       Impact factor: 9.812

4.  Allogeneic Hematopoietic Cell Transplantation in Patients With Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria Clones: Time for a Change.

Authors:  Eleni Gavriilaki; Ioanna Sakellari; Despina Mallouri; Ioannis Batsis; Thomas Chatziconstantinou; Anna Vardi; Zoi Bousiou; Marianna Masmanidou; Vassiliki Douka; Antonia Syrigou; Damianos Sotiropoulos; Varnavas Constantinou; Achilles Anagnostopoulos
Journal:  Hemasphere       Date:  2020-04-01

5.  Hematopoietic Stem Cell Transplantation for Patients with Paroxysmal Nocturnal Hemoglobinuria with or without Aplastic Anemia: A Multicenter Turkish Experience

Authors:  Fergün Yılmaz; Nur Soyer; Güldane Cengiz Seval; Sinem Civriz Bozdağ; Pervin Topcuoğlu; Ali Ünal; Leylagül Kaynar; Gökhan Özgür; Gülsan Sucak; Hakan Göker; Mustafa Velet; Hakan Özdoğu; Mehmet Yılmaz; Emin Kaya; Ozan Salim; Burak Deveci; İhsan Karadoğan; Güray Saydam; Fahri Şahin; Filiz Vural
Journal:  Turk J Haematol       Date:  2021-05-31       Impact factor: 1.831

Review 6.  How we('ll) treat paroxysmal nocturnal haemoglobinuria: diving into the future.

Authors:  Antonio Maria Risitano; Régis Peffault de Latour
Journal:  Br J Haematol       Date:  2021-08-05       Impact factor: 8.615
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.